Lupin Q2 net up 53% at Rs 116 cr

Written By DNA Web Team | Updated:

Drug maker Lupin has posted a net profit of Rs 115.62 crore for the second quarter ended September 30, a 52.85 per cent growth

MUMBAI: Drug maker Lupin has posted a net profit of Rs 115.62 crore for the second quarter ended September 30, a 52.85 per cent growth over the corresponding period a year ago.
    
The company had a net profit of Rs 75.64 crore in the second quarter of FY'08, Lupin said in a filing to the Bombay Stock Exchange.
    
The total consolidated income rose to Rs 934.31 crore in the quarter under review, from Rs 673.99 crore in the same period last fiscal.
    
For the six months ended on September 30, Lupin witnessed a jump of 73.62 per cent in net profit at Rs 228.14 over the same period last year. The company had a net profit of Rs 131.40 crore in the year-ago period.
    
Total consolidated income increased to Rs 1,814.27 crore during the six-month period, from Rs 1,260.61 crore in the year-ago period.
    
Shares of the company were trading at Rs 618, down 2.18 per cent in the early morning trade on the BSE.